SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-040582
Filing Date
2017-08-04
Accepted
2017-08-04 16:13:47
Documents
52
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v471866_10q.htm 10-Q 370216
2 EXHIBIT 31.1 v471866_ex31-1.htm EX-31.1 7483
3 EXHIBIT 31.2 v471866_ex31-2.htm EX-31.2 7382
4 EXHIBIT 32.1 v471866_ex32-1.htm EX-32.1 3980
5 EXHIBIT 32.2 v471866_ex32-2.htm EX-32.2 3970
  Complete submission text file 0001144204-17-040582.txt   3114368

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eyeg-20170630.xml EX-101.INS 541760
7 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20170630.xsd EX-101.SCH 32361
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20170630_cal.xml EX-101.CAL 31007
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20170630_def.xml EX-101.DEF 233572
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20170630_lab.xml EX-101.LAB 279029
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20170630_pre.xml EX-101.PRE 265712
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 171008781
SIC: 2834 Pharmaceutical Preparations